Apimeds Pharmaceuticals US, Inc
APUS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,390 | -$778 | -$669 | -$1,026 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $70 | $194 | $194 |
| Change in WC | $539 | $42 | -$2 | $3 |
| Other Non-Cash | $118 | $38 | $29 | $7 |
| Operating Cash Flow | -$734 | -$628 | -$448 | -$823 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $250 | $0 | $260 | $400 |
| Stock Issued | $0 | $1,055 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $77 | -$23 | $23 | $0 |
| Financing Cash Flow | $327 | $1,032 | $283 | $400 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$407 | $404 | -$165 | -$423 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $410 | $6 | $171 | $595 |
| End Cash | $3 | $410 | $6 | $171 |
| Free Cash Flow | -$734 | -$628 | -$448 | -$823 |